Improving the Yield and Quality of Daptomycin in by Multilevel Metabolic Engineering
Overview
Authors
Affiliations
Daptomycin is a cyclic lipopeptide antibiotic with a significant antibacterial action against antibiotic-resistant Gram-positive bacteria. Despite numerous attempts to enhance daptomycin yield throughout the years, the production remains unsatisfactory. This study reports the application of multilevel metabolic engineering strategies in to reconstruct high-quality daptomycin overproducing strain L2797-VHb, including precursor engineering (i.e., refactoring kynurenine pathway), regulatory pathway reconstruction (i.e., knocking out negative regulatory genes and ), byproduct engineering (i.e., removing pigment), multicopy biosynthetic gene cluster (BGC), and fermentation process engineering (i.e., enhancing O supply). The daptomycin titer of L2797-VHb arrived at 113 mg/l with 565% higher comparing the starting strain L2790 (17 mg/l) in shake flasks and was further increased to 786 mg/l in 15 L fermenter. This multilevel metabolic engineering method not only effectively increases daptomycin production, but can also be applied to enhance antibiotic production in other industrial strains.
Overproduction of endusamycin in subsp. .
Chang Y, Liu Z, Deng Z, Liu T Synth Syst Biotechnol. 2025; 10(2):523-531.
PMID: 40061181 PMC: 11889735. DOI: 10.1016/j.synbio.2025.02.004.
He F, Liu X, Wang H, Li X, Wu Y, Zhang D Microb Biotechnol. 2025; 18(3):e70110.
PMID: 40025688 PMC: 11872808. DOI: 10.1111/1751-7915.70110.
Metabolic engineering of for high-level production of pneumocandin B.
Zhang X, Cheng S, Yang J, Lu L, Deng Z, Bian G Synth Syst Biotechnol. 2025; 10(2):381-390.
PMID: 39830076 PMC: 11742615. DOI: 10.1016/j.synbio.2024.12.008.
Li X, Sang Z, Zhao X, Wen Y Microb Biotechnol. 2024; 17(11):e70038.
PMID: 39487765 PMC: 11530997. DOI: 10.1111/1751-7915.70038.
Xie H, Su Y, Bu Q, Li Y, Zhao Q, Du Y Synth Syst Biotechnol. 2024; 9(4):766-774.
PMID: 39021363 PMC: 11253128. DOI: 10.1016/j.synbio.2024.06.004.